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Currently available clonal sequencing instruments suchas the Illumina
GA II deliver gigabase-per-run sequence output. These instruments are
being exploited formany large scale sequencing studies, such as the 1000
genomes project (http://www.1000genomes.org). A variety of high-
performance assembly and alignment algorithms continue to be
developed to meet the needs of these very computationally intensive
programs of research [1]. Although clonal sequencing technology also has
great potential for more targeted sequencing needs, such as gene-centric
mutation detection, the informatics tools needed for its easy adoption
outside of specialist genome centers have been slow to appear.
Currently available alignment programs include MAQ [2], SOAP
[3], Bowtie [4] and BWA [5]. The general characteristics of these and
similar programs have recently been reviewed [1]. They achieve very
rapid alignment of reads to large genome-sized reference sequences,
typically by use of hash-table indexing and look-up (e.g. MAQ, SOAP),
or more recently, by use of faster Burrows–Wheeler transform
methods (Bowtie, BWA). In general, there is a trade-off between
alignment speed and tolerance to mismatches, although the charac-teristics of hash tables can be adjusted to allow detection of variable
numbers of mismatches within reads of a given length.
For diagnostic mutation detection, the desirable characteristics of a
sequence alignment program differ from those of most published
methods in at least two ways. Firstly, alignment speed is less critical,
because the target region of interest, will typically be small. The goal of
most diagnostic mutation analysis is to detect sequence variants within
speciﬁed target regions that might comprise one or a few genes of
known pathogenicity. Reference “genomes”, for such purposes, are on
the order of only 104–105 bp in size. Secondly, false negative outcomes
(failure to detect sequence variants that are actually represented in the
read data)must be kept to aminimum, even at the expense of alignment
speed and increased falsepositive rate. Some types of naturally occurring
mutation (such as complex indels) may be expected to be much more
difﬁcult to align than others, and short read lengths will render some
mutations intrinsically undetectable without resorting either to read-
pair data or to read depth analysis. Nonetheless, the analysis process
must be tolerant to as wide a spectrum of expected mutation types as
feasible, and should also be able to accomodate situations in which
alignment of reads containing pathogenicmutations is inﬂuenced by the
occurrence of nearby polymorphic variation.
Additional, utilitarian characteristics desirable in a mutation
analysis tool are that it should run within a standard desktop
computing environment, allow interactive visual inspection of data,
and require little specialist computer user knowledge. Here we
describe a novel software tool, Illuminator, designed to meet these
requirements and to allow sensitive mutation detection using
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performing gene-centric analysis, the high throughput of this
instrument is targeted towards massive read depth, permitting
high-order multiplexing of samples in order to achieve low unit cost
per clinical sample. The massive read depth is also required to offset
the lower accuracy of Illumina sequencing compared to the current
diagnostic “gold standard” capillary electrophoresis methods. A pre-
processing utility (Illuminator Data Extractor) performs simple
quality ﬁltering of the *_prb.txt output ﬁles from the Illumina GA II
pipeline, as well as sorting and stripping of the 5′-end “barcode” tags
that permit sample multiplexing. Illuminator then performs align-
ment to a speciﬁed reference sequence (using an indexed table of
octamer sequences) and automatic annotation of mutations, includ-
ing insertions and deletions. Both programs run under standard
Microsoft Windows desktop environments. Analysis of two long PCR
products encompassing TP53, sequenced in parallel on a single
channel of an Illumina ﬂow cell, showed that Illuminator could detect
all mutations identiﬁed by conventional Sanger sequencing, including
rs17878362, a frequent 16-bp indel variant in intron 3. The program
has also shown itself equal to commercial alternatives in the
multiplex analysis of BRCA1 and BRCA2 in breast cancer patients [6].
2. Materials and methods
2.1. Template preparation and sequencing
The protocol for multiplex sequencing DNA samples is described in
detail elsewhere [6]. In brief, theTP53 coding regionwas ampliﬁed in two
PCR products, of 3289 and 1234 bp, covering exons 2–9 and 10–11
respectively. Similarly the RHO coding sequences were ampliﬁed as two
PCR products of 3012 bp and 1753 bp. The BRCA1 and BRCA2 coding
regions were ampliﬁed as 22 separate PCR products ranging between
1221 bp and 5834 bp in length. Amplicons for each samplewere pooled,
sheared to ~200 bp, and a tagged fragment library prepared by ligation
to one of ten indexed adaptor oligonucleotides. Ten libraries bearing
different 6-nt index sequences were pooled for sequencing in a single
lane of an Illumina GAII ﬂowcell, using a single-read 51-cycle protocol.
TP53 mutation nomenclature relates to a 19,198-bp genomic reference
sequence, corresponding to the reverse complement of nt 7169069–
7188266 of NT_010718.15. BRCA1 and BRCA2 mutations relate to the
sequences in the contigs NT_010755.15 (4920610–5001764; BRCA1)
and NT_024524.13 (13869617–13953809; BRCA2) from the hg18
human genome assembly. The RHO reads were aligned against the
sequence of NT_005612.15 between 35742206 and 35747816 bp.
2.2. Software development and requirements
Programming was done using Microsoft Visual Studio 2005.
Illuminator and Illuminator Data Extractor require the .NET frame-
work 2.0 to be installed. Both programs have been tested onWindows
XP, Vista and Windows 7 and are freely available; downloads and
detailed user guides are at http://dna.leeds.ac.uk/illuminator/.
3. Results
3.1. Illuminator alignment algorithm
The algorithm is based on an indexed array of all possible 8-nt DNA
sequences (octamers), where the position of each octamer in both the
forward and reverse-complement reference sequence is listed against
the corresponding octamer sequence. Consequently the location(s) of
an octamer can be found in the reference sequence via this array,
allowing the rapid mapping of reads in both sequence orientations. To
allow the mapping of reads containing closely adjacent SNPs, the
alignment is performed in two cycles.3.1.1. First cycle
The ﬁrst 32 nt of each read is split into 4 non-overlapping octamers
and the possible positions of each octamer in the reference sequence
are found in the index. The program then searches for a set of
positions whose locations in the reference ﬁle increase stepwise by
8 nt for each adjacent octamer (Fig. 1A). The matching sequence read
is then compared to the reference sequence, to identify the positions
of any sequence variants within the remaining part of the read that
lies outside the region containing the four octamers.
If the read does not contain a run of 4 sequential matching
octamers, Illuminator tries to identify sets of octamers where the ﬁrst
and fourth octamers have the expected separation, along with one of
the internal octamers (Fig. 1B). Again, the read is then mapped to the
reference sequence to identify the positions of any sequence variants.
Finally, any unmapped read is checked for 3 consecutive octamer
positions in the reference sequence (Fig. 1C–D). As before, these reads
are mapped onto the reference sequence and the positions of any
sequence variants are noted.
3.1.2. Second cycle
All the sequence variants found in the ﬁrst cycle are now included
into the index, to incorporate both the original reference sequence and
the sequence variants found in the ﬁrst alignment cycle. This makes it
possible tomap readswhich containmultiple genuine sequencevariants
(including, for example, a pathogenic mutation close to a SNP). Such
reads would not have been aligned in the ﬁrst cycle, because only two
octamers would have been mapped close to each other (Fig. 1E–H).
The alignment process is now re-run, but this time, any read found
to be mismatched at either end (as in Fig. 1C or D) is stored to a
temporary ﬁle and used later to identify indels. In the case of reads
that can be mapped to multiple locations, Illuminator allows the
choice of various rule-sets for assigning such reads to one or other
target (see Appendix to online Guide).
Once the second round of analysis is complete, the locations of all
the sequence variants are noted. This information is then used to
identify single-nucleotide variants, including both known SNPs and
potentially pathogenic point mutations. Also, the read depth is
calculated, with the data split into three “phases”; the ﬁrst phase
comprises all the reads aligned as shown in Fig. 1A and B, while the
second and third phases comprises reads aligned with a 5′ (Fig. 1D) or
3′ (Fig. 1C) mismatch, respectively.
Although Fig. 1 shows a 32-nt read being mapped to the reference
sequence, with longer reads (currently tested to 76 nt), the ﬁrst 32 nt
is used to map the read and the extra 3′ sequence is passively aligned
to the reference as a continuation of the mapped proportion of the
read. Since the extra 3′-end sequence is not constrained by the
mapping process, it is very tolerant to the presence of sequence
variants. To minimize the detection of false positive variants in this
region, Illuminator Data Extractor (see below) only retains reads
with two or fewer uncalled positions and a read length of greater
than 32 nt.
3.1.3. Mapping indels
We found that short regions containing a large number of variants are
strongly indicative of the presence of an insertion or deletion. Therefore,
Illuminator checks the positions of variants to identify regions where an
unusual number of substitutions occur together within a region of 16 nt.
(These variants must be present in reads mapped to both orientations of
the reference sequence.) The locations of possible indels are noted and
the ﬂanking sequence is aligned to the sequence reads placed in the
temporary ﬁle during the second cycle of read alignment. This alignment
is done in the samemanner as shown in Fig. 1C-D, but the alignments for
the 5′ and 3′ mismatches to the forward and reverse-complement
sequences are kept separate, and used to create four sequences of about
50 nt in length. The 5′- and 3′-mismatched sequences are then aligned to
create a consensus sequence across the indel (for both the forward and
Fig. 1.Method employed by Illuminator to align reads. The ﬁrst 32 nt of the read (green) are split into octamers (black bars) that are matched to the reference sequence (blue) by
look-up in the octamer index table. In A, the four octamers are successfully matched to sequential index positions at 8-nt spacing. In B, the second octamer is mismatched, but the
read is successfully mapped by matching the ﬁrst and last octamers, together with one of the two internal octamers. In C and D, the read is mapped by ﬁnding three consecutive
octamers located at the correct spacings in the index. In B–D, the positions of the mismatched nucleotides are noted as possible sequence variants. E–H: Illuminator's method for
tolerating multiple adjacent sequence variants. The read shown in E would fail to be aligned, according to the criteria shown in A–D, because both its second and fourth octamers are
mismatched. However, after successful alignment of the two reads in F and G, the detected variants are represented in the newly indexed reference sequence (note S and R ambiguity
symbols), allowing alignment of all four octamers of the previously rejected read (H).
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aligned to the reference sequence, in order to identify the location and
sequence of an indel. Only indels that are independently identiﬁed on the
forward and reverse-complement sequences are annotated and
exported.
3.2. Implementation
3.2.1. Input sequence ﬁle format
The Illuminator alignment algorithm does not use quality score
weightings. Rather, reads are pre-ﬁltered according to user-speciﬁed
quality criteria. While various tools could be used for this purpose, we
provide a graphical interface-driven utility, “Illuminator Data Extrac-
tor” (IDE). This can quality-ﬁlter and reformat various input ﬁle types
into a format that Illuminator can use. Separating the pre-ﬁltering and
formatting of the sequences from the alignment and mutation calling
have two advantages; (i) it allows users to use their own scripts to
generate the input ﬁles of sequence reads and (ii) it allows
development of Illuminator to be independent of changes in Illumina
pipeline data ﬁle formats (which will be accommodated by substitut-
ing a new version of the IDE). Currently, IDE can read source ﬁles in
the *_prb.txt, *_qseq.txt or *_seq.txt formats from the pipeline, as well
as standard FASTA format.
3.2.2. User interface
Illuminator is aimed at facilitating rapid analysis of Illumina
sequence data by users without special computer skills. The alignment
and mutation detection algorithm has been implemented as a
graphical interface-driven desktop application, running on Windows
desktop operating systems, which performs four basic tasks:
1. Creation of custom reference ﬁles.
2. Alignment of reads to the reference sequence.Fig. 2. Illuminator “Global view”window. The sequence variants identiﬁed are shown in the c
are shown as pale blue and pink blocks, respectively.) This allows coding region variants to b
position (forward and reverse strands reads as blue and red graphs, respectively), allowin
viewed in this window, after importing a SNP library ﬁle. The variants are represented as colo
Note that since Illuminator cannot reliably determine pathogenicity, the assignment of eac3. Visualization of the aligned data, to identify sequence variants in
the genomic, cDNA and protein sequences and to allow correction
of errors in the annotation of indels.
4. Export of the aligned data and/or the annotated sequence variants.
To create a reference sequence, the user imports the genomic and
cDNA sequences of the gene as plain text ﬁles and selects the
appropriate open reading frame, before Illuminator aligns the cDNA to
the genomic sequence. Sub-regions of the genomic sequence may
then be chosen, that correspond to the regions actually sequenced
(e.g. as a series of long PCR products). To ease the task of creating
reference ﬁles for multiple genes, we also provide a stand-alone
program, “Illuminator Reference Files” to automate this process.
Due to the robustness of the alignment algorithm, only the
“Heterozygous cut-off” value is user-selectable, which deﬁnes a threshold
for declaring a sequence variant to be genuine. If this variable is set at 20,
an allele must comprise of at least 20% of the total aligned reads to be
called accepted.
The alignment data may be inspected in a “Global view” (Fig. 2),
which summarizes coverage and positions of identiﬁed sequence
variants, or a more detailed local “Data view”. The latter shows the
local sequence alignment over a short stretch of the reference
sequence and provides a detailed picture of the alignment for both
strands (Fig. 3). The “Global view” and “Data view” windows are
linked, such that changing the selected position in one window
automatically updates the other.
The “Indels” view shows the detailed sequence around putative
indels and also allows limitedmanual editing (Fig. 4). When analyzing
indels, the sense and antisense strands are processed independently
of each other, and an indel is called only if each strand gives the same
answer. This methodology is reﬂected in the “Indels” interface, which
shows the forward strand analysis (A-E in Fig. 4) above the reverse
strand analysis (a-e).ontext of the gene structure. (The locations of exons and parts of the open reading frame
e easily distinguished from intronic variants. This view also plots the read depth at each
g the identiﬁcation of regions of poor coverage. Known sequence variants can also be
r-coded bars; orange (unspeciﬁed), blue (polymorphisms) or red (pathogenic variants).
h variant must be performed manually at the time when it is included in the library.
Fig. 3. Illuminator's local “Data view”window. The upper (A–E) and lower (a–e) halves of the panel display alignment data for reads mapped respectively to the sense and antisense
strands. As in the “Global view”window, substitutions are highlighted with a gray background and the current position is bracketed by two vertical red lines. The deduced (patient)
and reference sequences are displayed along with read depth information, as follows. A,a: Any deduced (patient) sequence heterozygous positions are identiﬁed using the Y, R, W, S,
M or K IUPAC ambiguity symbols. B,b: Schematic representation of the relative proportion of each nucleotide mapped at a speciﬁc position. The plot imitates a conventional sequence
electropherogram, comprising “peaks” of four colors. Where 100% of the reads identify the same base, its peak will touch the upper dashed line, while if a position appears
heterozygous, with one nucleotide present in ~50% of the reads, its peak will reach only half way from the baseline. C,c: Reference genomic sequence. If the displayed region includes
any exonic or protein sequence, extra lines are written to display this, for the forward (sense) direction of the reference sequence only (C). D,d: These lines show the result of
deconvoluting the deduced (patient) DNA sequence to identify sequence changes. Where the patient and reference sequence match, this line will be identical to the reference
sequence; where they differ, the patient sequence is shown, if homozygous. Where a position is heterozygous, Illuminator subtracts the reference sequence from the patient
sequence, to identity the variant nucleotide. For example, if the reference and patient sequences are ACGCGT and ACSGGT, respectively, the novel sequence ACCGGT will be
displayed. E,e: Read depth at each position. F: The position in the original genomic reference sequence used to create the reference ﬁle is annotated, above the position in the long
PCR product (in brackets).
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includes the reference sequence, read depths and indel data, is much
smaller than the ﬁle(s) of unaligned data. Since these ﬁles contain the
entire alignment data used by illuminator, importing them gives the
same functionality obtained by re-analyzing the original data.
Information on annotated sequence variants can also be exported,
as tab-delimited text ﬁles (Supplementary Table 1). Variants located
within the open reading frame are annotated relative to the ﬁrst
nucleotide of the start codon and the variant codon is listed, together
with the equivalent nucleotide as deﬁned in the genomic and cDNA
reference sequences. If a sequence variant lies within a splice site, this,
rather than an amino-acid substitution, is recorded.
With repeated analyses of a given gene, increasing numbers of
SNPs (and rare single-nucleotide mutations) will be identiﬁed.
Illuminator can store this information in an updatable SNP library. If
this library is imported at the start of a new analysis, the variants
appear in “Global view” (Fig. 2).
3.3. Mutation detection
To test the ability of Illuminator to detect mutations in DNA
samples sequenced in parallel by template pooling, we screened theRHO (rhodopsin), TP53, BRCA1 and BRCA2 genes for sequences
variants in cohorts expected to be enriched for deleterious mutations.
The genomic sequences for each gene were ampliﬁed as a number of
long PCR products from each sample. Each patient's PCR products
were used to create a single tagged library, using a unique 6-nt 5′
sequence tag, and pools of tagged libraries were sequenced in a single
ﬂow-cell lane of an Illumina GA II sequencer.
The TP53 samples consisted of DNA from four established tumor cell
lines (HPAF, K562, Colo-741, Detroit-562), and DNA of ten Li-Fraumeni
syndromepatients, with knownheterozygous germlinemutations. Each
cell linewassequenced twiceper lane (i.e., 8 samplesper lane),while the
patient samples were sequenced once per lane. The rhodopsin genewas
sequenced in 20 individuals, of whom 19were known to be blind, and 7
hadpreviously been found tohaveheterozygous coding region sequence
variants known to be deleterious. To demonstrate the capability of our
method to handle a large number of different indexing tags, all 20
rhodopsin samples were sequenced in a single lane. Both the TP53 and
RHO genes were subsequently rescreened by Sanger sequencing. The
BRCA1 andBRCA2 sample originated from individuals at increased risk of
hereditary breast cancer and consistedof two sets of 55 and140 samples.
These samples were sequenced as tagged pools including both BRCA1
and BRCA2, from ten patients per lane. Samples in the smaller set had
Fig. 4. Illuminator's “Indels” window. Separate alignment results for forward- and reverse-strand reads appear. The ﬁrst line of each analysis (A and a) is the reference sequence
spanning the putative indel. Next are shown the results of reads aligned (to that strand) 5′ to the indel (B and b) and 3′ to the indel (C and c). Lines D and d show consensus
sequences across the indel, derived by aligning sequences B to C and b to c. Finally, the alignment of the reference sequence and the patient consensus sequence is shown (E and e). In
this example, the alignment identiﬁes a 3-nt deletion (red box). Only if the same indel is found in both E and e alignments is the indel annotated when the sequence variants are
exported; otherwise, the estimated approximate position of the indel will be listed. The consensus sequences (D and d) can bemanually adjusted using the input boxes in the “Adjust
alignments” panel. Changing the number in the “Forward” list-box moves the position of the sequence in line C relative to the B line sequence, which in turn changes the consensus
sequence in line D and the alignment E. Similarly, the “Reverse” list-box adjusts lines c, d and e. Pressing the “R” button resets these values to their original offsets. If these values are
changed, the new alignment will be used when annotating and exporting the sequence variants.
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Illuminator of both sets were compared to those obtained on analyzing
the same sequence data using NextGene (Softgenetics, State College,
PA). Variants identiﬁed by capillary sequencing and the clonal
sequencing software are recorded in two databases at http://mme-
pc2050.leeds.ac.uk/Mutations/ for the smaller dataset and http://mme-
pc2050.leeds.ac.uk/IlluminatorData for the larger dataset. Themutations
present in the TP53 and smaller BRCA1 and BRCA2 data sets have been
described elsewhere [6].
Illuminator data extractorwasused to convert the *_prb.txt sequence
probability ﬁles into multiple FASTA ﬁles of sequence reads, each
containing sequences with a unique 5′ tag. Reads were discarded if the
Illumina quality score for any position in the 5′ tag was less than 5, and
any position in the remainder of read with a quality score of less than 5
was assigned as uncalled (“n”). The 5′ tag was removed, and all reads
were truncated at the position preceding the third uncalled positions.
(e.g. if a nucleotidewas uncalled at positions 10, 15 and 34, the exported
sequencewould only include the sequence up to position 33.) If theﬁnal
read length was less than 32 nt, the sequence was discarded.
3.3.1. Single-base variants
3.3.1.1. TP53 and RHO. Sorted readswere aligned to the19-kb TP53 or 5-
kb rhodopsin genomic reference sequence using Illuminator. (On a dual-
core 2-GHz processor, 0.5 million reads – representing those from one
patient – were aligned in ~6 s.) The analysis identiﬁed twelve single-
nucleotide substitutions and two frame-shifting insertions in the TP53
cell line data set, with complete concordance between the differently
tagged replicates (Table 1). These variants included all those previouslyidentiﬁed by Sanger sequencing. Among the 10 Li-Fraumeni patients, 19
single-nucleotide substitutions were identiﬁed (Table 2), including all
the pathogenic mutations. Among the 20 individuals in whom RHOwas
simultaneously sequenced in a single lane, 12 different single-base
variants were found (Table 3). Again, these included all the variants
previously identiﬁed by Sanger sequencing, conﬁrming the capability to
perform sequencing at highmultiplex levelswithout losing the ability to
detect heterozygous changes.
3.3.1.2. BRCA1 and BRCA2. Sorted reads were aligned to a total of
65,159 bp of the BRCA1 and BRCA2 loci, of which 16,032 bp was
coding sequence. In the combined datasets (195 cases), 818
instances of 26 different single-base substitutions and 15 instances
of 8 indel variants were identiﬁed in the BRCA1 coding sequence.
Similarly, 996 instances of 51 single-base substitutions and 35
instances of 19 indels were found in the protein-coding sequence of
BRCA2 (Supplementary Table 4). Using the default Illuminator
threshold for variant calling (≥20% of reads), this set of variants
was identical to those identiﬁed by NextGene.
3.3.1.3. Simulated mutations. For a systematic test of Illuminator's
ability to detect single-nucleotide changes, we simulated sets of
sequence reads containing heterozygous substitutions. First, a set of
24 positions was randomly chosen within the TP53 coding region. All
three possible substitutions at each of these positions were simulated
in heterozygous state, generating 72 (24×3) derivative FASTA ﬁles
that were each heterozygous at one of the 24 positions. This was
done by scanning all the initial reads in a real experimental FASTA
data ﬁle, for the presence of the 8mer sequences immediately 5′ or 3′ to
Table 1
TP53 sequence variants identiﬁed by Illuminator in the four tumor cell lines. An asterisk in
the last column indicates that that variantmatches thepresumptively pathogenicmutation
recorded in the COSMIC database [7] [http://www.sanger.ac.uk/genetics/CGP/cosmic/].
Variant Cell line(s)
Genomic cDNA Protein
g.11117 CNG Intronic Non-coding HPAF
g.11299 CNA Intronic Non-coding Colo-741, K562
g.11446 CNG c.215 CNG p.72PNR HPAF
g.12081 TNC Intronic Non-coding Colo-741, K562, HPAF
g.12239 TNC Intronic Non-coding Colo-741, K562
g.12247 GNA Intronic Non-coding Colo-741, K562
g.12273 GNA Intronic Non-coding Colo-741, K562, HPAF
g.12394_12395insC c.406_407insC Frameshift K562*
g.12439 CNT c.451 CNT p.151PNS HPAF*
g.12512 GNA c.524 GNA p.175RNH Detroit-562*
g.12803ANG Intronic Non-coding Colo-741, K562, HPAF
g.13274 GNC Intronic Non-coding HPAF
g.14035_14036insAA c.963_964insAA Frameshift Colo-741*
g.17689 GNA Intronic Non-coding Colo-741, K562
Table 3
Rhodopsin variants found in or within 50 bp of the coding sequence, in 20 individuals
(19 blind and 1 control), of whom 7 (**) were heterozygous for known deleterious
mutations (http://www.retina-international.org/sci-news/rhomut.htm).
Variant Number of
homozygous
individuals
Number of
heterozygous
individuals
Genomic cDNA Protein
g.571ANG c.-26ANG Non-coding 4 5
g.646 CNT c.50 CNT p.17 TNM 0 1**
g.769 CNG c.173 CNG p.58 TNR 0 2**
g.786 CNT c.190 CNT p.64QNX 0 1**
g.2780 CNT c.403 CNT p.135RNW 0 1**
g.4015 GNA Intronic Non-coding 0 1
g.4116ANG c.533ANG p.178YNC 0 1**
g.4283 CNT 3′ splice site Non-coding 2 4
g.4510 GNA c.811 GNA p.271 VNM 0 1
g.5544 TNC c.1010 TNC p.337 VNA 0 1
g.5574 CNT c.1040 CNT p.347PNL 0 1**
g.5624 CNA c.1090 CNA Non-coding 2 4
308 I.M. Carr et al. / Genomics 98 (2011) 302–309eachmutation site. Forpositive reads, eachof the3possible substitutions
was introduced randomly into half of the reads. Note that the simulated
mutant read sets were thus not preﬁltered by the Illuminator alignment
algorithm. Using these simulated data sets, Illuminator correctly
identiﬁed and annotated all 72 sequence variants.
3.3.2. Insertions and deletions
Illuminator detected a number of apparent insertions and de-
letions in intronic regions that tended to occur within or adjacent to
the poly(dA) mononucleotide repeats found in Alu elements.
Inspection of reads mapped to these locations suggested that the
apparent insertions and deletions were the result of polymerase
“slippage” across the poly(dA) repeat during PCR or sequencing.
While not problematic for the speciﬁc example of TP53 analysis, this
type of artifact could be signiﬁcant in regions that include Alu or other
mononucleotide repeats.
For a systematic survey of Illuminator's ability to detect and
annotate genuine insertions and deletions, a number of variants were
introduced into FASTA ﬁles from a typical TP53 sequence run (one
variant per ﬁle). Supplementary Tables 2a–c list the results of analysisTable 2
TP53 variants found in constitutional DNA of ten Li-Fraumeni syndrome patients. The
pathogenic mutations are indicated by asterisks in the last column; two asterisks
indicate that the mutation has been previously reported in Li-Fraumeni families, as
recorded in the IARC TP53 mutation database; http://www-p53.iarc.fr/index.html.
Variant Number of
homozygous
individuals
Number of
heterozygous
individuals
Genomic cDNA Protein
g.11117 CNG Intronic Non-coding 5 4
g.11446 CNG c.215 CNG p.72PNR 6 3
g.11605 CNG c.374 CNG p.125 TNR 0 1**
g.12081 TNC Intronic Non-coding 8 1
g.12273 GNA Intronic Non-coding 8 1
g.12418 CNT c.430 CNT p.144QNX 0 1*
g.12461 GNA c.473 GNA p.158RNH 0 2**
g.12461 GNC c.473 GNC p.158RNP 0 1*
g.12803ANG Intronic Non-coding 8 1
g.12961 GNT Intronic Non-coding 0 1
g.13209 GNA Intronic Non-coding 0 1
g.13274 GNC Intronic Non-coding 0 1
g.13363 CNA c.726 CNA p.242 CNX 0 1*
g.13380 GNA c.743 GNA p.248RNQ 0 2**
g.13403ANG c.766ANG p.256 TNA 0 1*
g.13491 CNT Intronic Non-coding 0 2
g.13511 TNG Intronic Non-coding 0 2
g.13798 GNA c.818 GNA p.273RNH 0 1**
g.17689 GNA Intronic Non-coding 0 1of these ﬁles, classiﬁed according to whether Illuminator correctly
annotated the variant, detected the variant but failed to correctly
annotate it, or failed to detect the variant. It can be seen that typically
Illuminator correctly annotated deletions b16 nt, insertions b6 nt, and
indels b6 nt. The commonest errors were in the annotation of
complex indels, although even then, Illuminator nonetheless identi-
ﬁed their locations (Supplementary Table 2c).
The user-selectable “heterozygous cut-off” value speciﬁes the mini-
mum proportion of reads that must contain a variant in order for
Illuminator to declare heterozygosity. For germline variants, this has a
predictable impact on the sensitivity of detection (Supplementary Table 3
and Supplementary Fig. 1). The default value (0.2) is suitable for most
purposes.
4. Discussion
In contrast to most other high-performance short read aligners for
clonal sequencing output, Illuminator has been designed speciﬁcally for
comparison of reads to small target regions (rather than whole genomes
or transcriptomes). Its design features are accordingly adapted to the
needs ofmutationdetectionwithin gene(s) of knownclinical signiﬁcance.
When screening for an unknown mutation, typically there is no
way to prove that a rare intronic variant is disease-causing.
Consequently, diagnostic sequencing experiments tend to focus on
exons and splice junctions. Illuminator offers the capability to use
reference sequences that contain only these regions, and are therefore
much smaller than those used in genome-wide approaches. Since the
time taken to align a read is a function of the length of the reference
sequence, these small reference sequences allow Illuminator to use a
slower mismatch-tolerant alignment algorithmwhile still performing
the mapping of millions of reads in a few seconds.
In order to minimize memory requirements, Illuminator does not
retain the sequence of each read. As a consequence, unlike some other
alignment programs, Illuminator cannot display the phase of two
variants found on the same read. While the phase relationship
between variantsmay sometimes be of interest, the short read lengths
currently obtained from the Illumina GA II means that in practice, two
variants of interest are seldom close enough to identify phase. At
present, therefore, the advantage of low memory usage more than
offsets the sacriﬁce of phase data.
Short-read alignment programs must decide where to place reads
that could be aligned tomore than one location (e.g. when the reference
sequence includes paralogous duplicated sequences). In such situations,
Illuminator alwaysmaps a read to the ﬁrst copy of the duplication. Some
alignment programs, in contrast, randomly assign reads to all possible
matching targets, so that reads are distributed evenly across the
duplicated sequences. We decided against this approach, since it does
309I.M. Carr et al. / Genomics 98 (2011) 302–309not help the identiﬁcation or correct placement of sequence variants.
Paralogous duplicated sequences are in fact not easily amenable to
mutation analysis by short-read sequencing; alternative methods are
needed for analysis of such regions.
It is to be expected that short read lengths will impose limits on the
ability of any alignment program to identify some types of mutation,
particularly insertions and deletions. In our test data set, Illuminator
correctly annotated all single base sequence variants found by
conventional Sanger sequencing, as well as a further 72 simulated
SNPs. In contrast, the program did not correctly annotate all insertions
and deletions; nonetheless, their presence was detected by manual
observation of the alignment via the user interface. Illuminator was
better able to annotate deletions than insertions, while its ability to
annotate complex insertions–deletionswas dependant on the size of the
inserted rather than the deleted fragments. It was also noted that the
presence of SNPs adversely affected the correct annotation of insertions
and indels, but not the identiﬁcation of single base changes.
In practice, it is likely to remain desirable that clinically important
variants identiﬁed by short-read approaches are validated by a second
method such as Sanger sequencing. The economies deriving from the
massive throughput of clonal sequencing approaches, however, make it
highly attractive as a primary mutation-screening technology.
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